Oral semaglutide + tirzepatide vs single-agent GLP-1 options
Surfbound offers a compounded oral semaglutide + tirzepatide combination at $365/mo, plus two single-agent oral options — oral semaglutide at $259/mo and oral tirzepatide at $298/mo — each chosen by a licensed provider, never by self-selection.
Prescription required. Not everyone qualifies. Individual results vary.
Who should compare oral options
Who should ask about the oral combination vs a single agent?
Surfbound Health is for adults who want to avoid injections and are weighing both oral semaglutide and tirzepatide against a single agent. No FDA-approved combination exists, so any combination is compounded and not FDA-approved, and a licensed provider - not a menu selection - decides whether a combination, a single agent, or no treatment is appropriate.
Common questions about combination vs single-agent
- How do I decide between an oral combination and a single oral agent?
- That is a clinical decision for a licensed provider, not a menu choice. You share your history and goals during intake, and the provider weighs whether the compounded oral combination, a single oral agent, or an injectable is most appropriate.
- Is the oral combination more effective than oral semaglutide alone?
- That is a clinical judgment, not something to self-select. Each medication has its own established evidence base, and a licensed provider weighs your history and goals to decide whether a combination or a single agent fits you better.
- Can my provider switch me from a single agent to the combination later?
- Possibly, if it is medically appropriate. Changing agents is a provider decision made after reviewing your response and history - not a self-service change. If you want to revisit it, raise it with support and a licensed provider will assess whether a switch makes sense.
- Does the combination raise the risk of side effects compared with one agent?
- Your licensed provider reviews any potential side effects with you and weighs benefits and risks before deciding whether a combination or a single agent is appropriate. GLP-1 medications commonly include gastrointestinal effects such as nausea.
- If I am new to GLP-1s, should I start with the combination or a single tablet?
- For most people new to GLP-1 treatment, a provider often starts with a single agent so the response is easier to follow. That is a general principle, not a rule - a licensed provider looks at your history and decides, and the combination is not intended as an automatic first choice.
Quick comparison at a glance
Surfbound offers a compounded combination oral, plus two separate single-agent oral options. No approved medication provides a combined semaglutide + tirzepatide tablet.
| Factor | Combination | Oral Semaglutide | Oral Tirzepatide |
|---|---|---|---|
| Availability | Offered (compounded) | Offered | Offered |
| Active ingredient(s) | Semaglutide + tirzepatide (compounded) | Semaglutide | Tirzepatide |
| Receptor target | GLP-1 + GLP-1/GIP receptors | GLP-1 receptor | GLP-1 and GIP receptors |
| Format | Daily oral | Daily tablet | Daily tablet |
| Price | $365/month, all doses | $259/month, all doses | $298/month, all doses |
| FDA approval | Compounded | Compounded | Compounded |
| Who decides | Licensed provider | Licensed provider | Licensed provider |
The combination option (compounded)
Semaglutide and tirzepatide both act on the GLP-1 receptor, and tirzepatide additionally acts on the GIP receptor. Each medication has its own established evidence base, and a licensed provider weighs your individual health history to decide which option, if any, is appropriate.
There is no FDA-approved medication that combines semaglutide and tirzepatide, so any such combination is a compounded product prepared by a licensed compounding pharmacy.
Surfbound Health offers a compounded oral semaglutide + tirzepatide combination, plus single-agent options. A licensed provider selects the appropriate option — the compounded combination, oral semaglutide, or oral tirzepatide — based on your individual health history.
Your two single-agent oral options
These are two separate medications, not a combination. A licensed provider determines which — if either — is appropriate for you.
Oral semaglutide
- Receptor
- GLP-1 receptor
- Format
- Daily tablet
A single-agent GLP-1 receptor agonist taken once daily by mouth. Reviewed by a licensed provider for medical appropriateness.
Oral tirzepatide
- Receptor
- GLP-1 and GIP receptors
- Format
- Daily tablet
A single-agent dual-agonist taken once daily by mouth. Reviewed by a licensed provider for medical appropriateness.
Medication included if prescribed. No membership fee, no hidden charges. Not all patients qualify.
How the evidence differs
The key distinction is what is approved for each option.
Semaglutide
Acts on the GLP-1 receptor. Injectable semaglutide has a large body of FDA-reviewed clinical trial evidence for weight loss. Oral semaglutide as a compounded daily tablet is not FDA-approved.
Tirzepatide
Acts on both the GLP-1 and GIP receptors. Injectable tirzepatide has FDA-reviewed clinical trial evidence for weight loss. Compounded oral tirzepatide is not FDA-approved, and there is no FDA-approved oral tirzepatide.
Combination
Each medication has its own established evidence base. No combined semaglutide + tirzepatide medication is FDA-approved; the combination Surfbound offers is a compounded product.
Important things to keep in mind
- Compounded medications, including Surfbound’s oral options, are not FDA-approved; they are prepared by licensed compounding pharmacies for individual patients.
- Individual response to any GLP-1 medication varies. There is no way to predict in advance how any single person will respond.
- Prescription is never automatic — a licensed provider determines whether any option is medically appropriate for you.
How the provider decides
You never choose between these options yourself. A licensed provider makes the decision based on your individual health history, contraindications, and clinical judgment.
- 1
Complete a secure intake
Answer a short health questionnaire online in about 5–10 minutes. No appointment or waiting room.
- 2
A licensed provider reviews your case
An independent licensed provider reviews your full health history and determines which single-agent oral option, if any, is medically appropriate.
- 3
Medication ships if prescribed
If treatment is prescribed, medication ships discreetly from a pharmacy partner with instructions for taking it daily by mouth.
Frequently asked questions
Surfbound Health offers a compounded oral semaglutide + tirzepatide combination from $365/month. There is no FDA-approved medication that combines semaglutide and tirzepatide. Surfbound also offers compounded oral semaglutide and compounded oral tirzepatide as separate, single-agent daily tablets, each reviewed by a licensed provider.
Surfbound Health charges a flat $259/month for compounded oral semaglutide, all doses, taken as a daily tablet. The price includes the medication if prescribed, licensed provider review, ongoing dosing support, and discreet shipping. There are no membership or consultation fees.
Surfbound Health charges a flat $298/month for compounded oral tirzepatide, all doses, taken as a daily tablet. The price includes the medication if prescribed, licensed provider review, ongoing dosing support, and discreet shipping. There are no membership or consultation fees.
Semaglutide acts primarily on the GLP-1 receptor. Tirzepatide acts on both the GLP-1 and GIP receptors. They are two different single-agent medications with different mechanisms of action. A licensed provider determines which, if either, is medically appropriate for you based on your individual health history.
You should not self-select. The choice between oral semaglutide and oral tirzepatide is a clinical decision made by a licensed provider after reviewing your full health history.
No. No combined semaglutide and tirzepatide medication is FDA-approved. Surfbound’s combination is a compounded product prepared by a licensed compounding pharmacy, and compounded medications — including Surfbound’s oral options — are not FDA-approved.
Any change between GLP-1 medications should be directed by a licensed provider. Switching requires a fresh clinical review and individualized dosing guidance. You should not switch or combine these medications on your own.
Yes. Both oral semaglutide and oral tirzepatide are prescription medications. A licensed provider must review your health history and determine whether treatment is medically appropriate before any prescription is issued. Prescription is never automatic, and not everyone qualifies.
Let a provider determine your path
Take a few minutes for the online intake. A licensed provider weighs your history and picks the single-agent oral option that fits — or decides none is appropriate. You'll only be charged if your medication is approved.
Start onlinePrescription required, and qualification is decided by a provider.